Table 3.
Comparison of clinopathologic variables among different risk groups
Variable | Group 3 | Group2 | Group1 | p-value |
---|---|---|---|---|
Age (yr) | 0.341 | |||
< 60 | 88 | 119 | 95 | |
≥ 60 | 91 | 101 | 72 | |
Gender | 0.228 | |||
Male | 124 | 154 | 204 | |
Female | 55 | 66 | 63 | |
Primary T stage | 0.661 | |||
T1 | 1 | 3 | 1 | |
T2 | 2 | 5 | 2 | |
T3 | 149 | 177 | 141 | |
T4 | 18 | 30 | 15 | |
NA | 9 | 5 | 8 | |
Primary N stage | 0.368 | |||
N0 | 50 | 55 | 46 | |
N1 | 60 | 84 | 53 | |
N2 | 52 | 73 | 68 | |
NA | 17 | 8 | 0 | |
Tumor grade | 0.215 | |||
Well differentiated | 17 | 20 | 17 | |
Moderately differentiated | 134 | 169 | 119 | |
Poorly differentiated | 19 | 16 | 19 | |
Mucinous | 2 | 0 | 0 | |
Signet ring cell | 1 | 7 | 6 | |
NA | 6 | 8 | 6 | |
No. of metastases | < 0.001 | |||
1 | 3 | 40 | 109 | |
> 1 | 176 | 180 | 58 | |
Size of largest metastasis (cm) | 0.012 | |||
≤ 5 | 134 | 183 | 145 | |
> 5 | 45 | 37 | 22 | |
Distribution of liver metastasis | < 0.001 | |||
Single | 2 | 75 | 167 | |
Both | 177 | 145 | 0 | |
CEA (ng/mL) | < 0.001 | |||
≤ 200 | 88 | 214 | 167 | |
> 200 | 91 | 6 | 0 | |
Disease-free interval (mo) | < 0.001 | |||
≥ 12 | 52 | 151 | 167 | |
< 12 | 127 | 69 | 0 | |
Fong's score | < 0.001 | |||
0-2 | 34 | 166 | 159 | |
0 (low) | 0 | 0 | 28 | |
1 | 2 | 41 | 85 | |
2 | 32 | 125 | 46 | |
3-5 | 145 | 54 | 8 | |
3 (high) | 89 | 50 | 8 | |
4 | 45 | 4 | 0 | |
5 | 11 | 0 | 0 |
Chi-square test was used. NA, not available; CEA, carcinoembryonic antigen.